世界の白血病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Leukemia Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3404 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、白血病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（グリベック、スプリセル、タシグナ、クロラー、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・白血病治療の市場動向 ・企業の競争状況、市場シェア ・白血病治療の種類別市場規模（グリベック、スプリセル、タシグナ、クロラー、その他） ・白血病治療の用途別市場規模（病院、クリニック） ・白血病治療の北米市場規模2016-2027（アメリカ、カナダ） ・白血病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・白血病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・白血病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・白血病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、GlaxoSmithKline、Novartis、Bristol-Myers Squibb、Eisai、Biogen Idec、ERYtech Pharma、Celgene、Genmab、Cephalon、Clavis Pharma、Pfizer） ・結論

Market Analysis and Insights: Global Leukemia Therapeutics Market
The global Leukemia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Leukemia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Leukemia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Leukemia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Leukemia Therapeutics market.

Global Leukemia Therapeutics Scope and Market Size
Leukemia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Leukemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Gleevec
Sprycel
Tasigna
Clolar
Others

Segment by Application
Hospital
Clinic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
GlaxoSmithKline
Novartis
Bristol-Myers Squibb
Eisai
Biogen Idec
ERYtech Pharma
Celgene
Genmab
Bristol-Myers Squibb

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gleevec
1.2.3 Sprycel
1.2.4 Tasigna
1.2.5 Clolar
1.2.6 Others
1.3 Market by Application
1.3.1 Global Leukemia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Leukemia Therapeutics Market Perspective (2016-2027)
2.2 Leukemia Therapeutics Growth Trends by Regions
2.2.1 Leukemia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Leukemia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Leukemia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Leukemia Therapeutics Industry Dynamic
2.3.1 Leukemia Therapeutics Market Trends
2.3.2 Leukemia Therapeutics Market Drivers
2.3.3 Leukemia Therapeutics Market Challenges
2.3.4 Leukemia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Leukemia Therapeutics Players by Revenue
3.1.1 Global Top Leukemia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Leukemia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Leukemia Therapeutics Revenue
3.4 Global Leukemia Therapeutics Market Concentration Ratio
3.4.1 Global Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Therapeutics Revenue in 2020
3.5 Leukemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Leukemia Therapeutics Product Solution and Service
3.7 Date of Enter into Leukemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Leukemia Therapeutics Breakdown Data by Type
4.1 Global Leukemia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Leukemia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Leukemia Therapeutics Breakdown Data by Application
5.1 Global Leukemia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Leukemia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Leukemia Therapeutics Market Size (2016-2027)
6.2 North America Leukemia Therapeutics Market Size by Type
6.2.1 North America Leukemia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Leukemia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Leukemia Therapeutics Market Size by Type (2016-2027)
6.3 North America Leukemia Therapeutics Market Size by Application
6.3.1 North America Leukemia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Leukemia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Leukemia Therapeutics Market Size by Application (2016-2027)
6.4 North America Leukemia Therapeutics Market Size by Country
6.4.1 North America Leukemia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Leukemia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Leukemia Therapeutics Market Size (2016-2027)
7.2 Europe Leukemia Therapeutics Market Size by Type
7.2.1 Europe Leukemia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Leukemia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Leukemia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Leukemia Therapeutics Market Size by Application
7.3.1 Europe Leukemia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Leukemia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Leukemia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Leukemia Therapeutics Market Size by Country
7.4.1 Europe Leukemia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Leukemia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Leukemia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Leukemia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Leukemia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Leukemia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Leukemia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Leukemia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Leukemia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Leukemia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Leukemia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Leukemia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Leukemia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Leukemia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Leukemia Therapeutics Market Size (2016-2027)
9.2 Latin America Leukemia Therapeutics Market Size by Type
9.2.1 Latin America Leukemia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Leukemia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Leukemia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Leukemia Therapeutics Market Size by Application
9.3.1 Latin America Leukemia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Leukemia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Leukemia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Leukemia Therapeutics Market Size by Country
9.4.1 Latin America Leukemia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Leukemia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Leukemia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Leukemia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Leukemia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Leukemia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Leukemia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Leukemia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Leukemia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Leukemia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Leukemia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Leukemia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Leukemia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Leukemia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Leukemia Therapeutics Introduction
11.1.4 Roche Revenue in Leukemia Therapeutics Business (2016-2021)
11.1.5 Roche Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Leukemia Therapeutics Introduction
11.2.4 GlaxoSmithKline Revenue in Leukemia Therapeutics Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Leukemia Therapeutics Introduction
11.3.4 Novartis Revenue in Leukemia Therapeutics Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Leukemia Therapeutics Introduction
11.4.4 Bristol-Myers Squibb Revenue in Leukemia Therapeutics Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Eisai Business Overview
11.5.3 Eisai Leukemia Therapeutics Introduction
11.5.4 Eisai Revenue in Leukemia Therapeutics Business (2016-2021)
11.5.5 Eisai Recent Development
11.6 Biogen Idec
11.6.1 Biogen Idec Company Details
11.6.2 Biogen Idec Business Overview
11.6.3 Biogen Idec Leukemia Therapeutics Introduction
11.6.4 Biogen Idec Revenue in Leukemia Therapeutics Business (2016-2021)
11.6.5 Biogen Idec Recent Development
11.7 ERYtech Pharma
11.7.1 ERYtech Pharma Company Details
11.7.2 ERYtech Pharma Business Overview
11.7.3 ERYtech Pharma Leukemia Therapeutics Introduction
11.7.4 ERYtech Pharma Revenue in Leukemia Therapeutics Business (2016-2021)
11.7.5 ERYtech Pharma Recent Development
11.8 Celgene
11.8.1 Celgene Company Details
11.8.2 Celgene Business Overview
11.8.3 Celgene Leukemia Therapeutics Introduction
11.8.4 Celgene Revenue in Leukemia Therapeutics Business (2016-2021)
11.8.5 Celgene Recent Development
11.9 Genmab
11.9.1 Genmab Company Details
11.9.2 Genmab Business Overview
11.9.3 Genmab Leukemia Therapeutics Introduction
11.9.4 Genmab Revenue in Leukemia Therapeutics Business (2016-2021)
11.9.5 Genmab Recent Development
11.10 Cephalon
11.10.1 Cephalon Company Details
11.10.2 Cephalon Business Overview
11.10.3 Cephalon Leukemia Therapeutics Introduction
11.10.4 Cephalon Revenue in Leukemia Therapeutics Business (2016-2021)
11.10.5 Cephalon Recent Development
11.11 Clavis Pharma
11.11.1 Clavis Pharma Company Details
11.11.2 Clavis Pharma Business Overview
11.11.3 Clavis Pharma Leukemia Therapeutics Introduction
11.11.4 Clavis Pharma Revenue in Leukemia Therapeutics Business (2016-2021)
11.11.5 Clavis Pharma Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Leukemia Therapeutics Introduction
11.12.4 Pfizer Revenue in Leukemia Therapeutics Business (2016-2021)
11.12.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Leukemia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gleevec
Table 3. Key Players of Sprycel
Table 4. Key Players of Tasigna
Table 5. Key Players of Clolar
Table 6. Key Players of Others
Table 7. Global Leukemia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Leukemia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Leukemia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Leukemia Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Leukemia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Leukemia Therapeutics Market Share by Regions (2022-2027)
Table 13. Leukemia Therapeutics Market Trends
Table 14. Leukemia Therapeutics Market Drivers
Table 15. Leukemia Therapeutics Market Challenges
Table 16. Leukemia Therapeutics Market Restraints
Table 17. Global Leukemia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Leukemia Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Therapeutics as of 2020)
Table 20. Ranking of Global Top Leukemia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Leukemia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Leukemia Therapeutics Product Solution and Service
Table 24. Date of Enter into Leukemia Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Leukemia Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Leukemia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Leukemia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Leukemia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Leukemia Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Leukemia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Leukemia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Leukemia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Leukemia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Leukemia Therapeutics Product
Table 67. Roche Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Roche Recent Development
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Leukemia Therapeutics Product
Table 72. GlaxoSmithKline Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Leukemia Therapeutics Product
Table 77. Novartis Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Leukemia Therapeutics Product
Table 82. Bristol-Myers Squibb Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Eisai Company Details
Table 85. Eisai Business Overview
Table 86. Eisai Leukemia Therapeutics Product
Table 87. Eisai Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Eisai Recent Development
Table 89. Biogen Idec Company Details
Table 90. Biogen Idec Business Overview
Table 91. Biogen Idec Leukemia Therapeutics Product
Table 92. Biogen Idec Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Biogen Idec Recent Development
Table 94. ERYtech Pharma Company Details
Table 95. ERYtech Pharma Business Overview
Table 96. ERYtech Pharma Leukemia Therapeutics Product
Table 97. ERYtech Pharma Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 98. ERYtech Pharma Recent Development
Table 99. Celgene Company Details
Table 100. Celgene Business Overview
Table 101. Celgene Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Celgene Recent Development
Table 103. Genmab Company Details
Table 104. Genmab Business Overview
Table 105. Genmab Leukemia Therapeutics Product
Table 106. Genmab Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Genmab Recent Development
Table 108. Cephalon Company Details
Table 109. Cephalon Business Overview
Table 110. Cephalon Leukemia Therapeutics Product
Table 111. Cephalon Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Cephalon Recent Development
Table 113. Clavis Pharma Company Details
Table 114. Clavis Pharma Business Overview
Table 115. Clavis Pharma Leukemia Therapeutics Product
Table 116. Clavis Pharma Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 117. Clavis Pharma Recent Development
Table 118. Pfizer Company Details
Table 119. Pfizer Business Overview
Table 120. Pfizer Leukemia Therapeutics Product
Table 121. Pfizer Revenue in Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 122. Pfizer Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leukemia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Gleevec Features
Figure 3. Sprycel Features
Figure 4. Tasigna Features
Figure 5. Clolar Features
Figure 6. Others Features
Figure 7. Global Leukemia Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Leukemia Therapeutics Report Years Considered
Figure 11. Global Leukemia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Leukemia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Leukemia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Leukemia Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Leukemia Therapeutics Market Share by Players in 2020
Figure 16. Global Top Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Leukemia Therapeutics Revenue in 2020
Figure 18. Global Leukemia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Leukemia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Leukemia Therapeutics Market Share by Region (2016-2027)
Figure 40. China Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021)
Figure 63. Eisai Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021)
Figure 64. Biogen Idec Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021)
Figure 65. ERYtech Pharma Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021)
Figure 66. Celgene Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021)
Figure 67. Genmab Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021)
Figure 68. Cephalon Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021)
Figure 69. Clavis Pharma Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Leukemia Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---